The association of nasal airway obstruction with health is significant, and the health care resources utilized in open septorhinoplasty need to be included in health economic analyses.
N asal airway obstruction encompasses several conditions that hinder airflow of the nose, with causes such as septal deviation, nasal valve collapse, turbinate hypertrophy, and rhinitis. It is a common condition in otolaryngology practice and can have significant effects on sinonasal function and overall health. 1 Despite its prevalence and high costs to the health care system, nasal airway obstruction and its treatment remain difficult to assess because objective measures do not necessarily correlate with patients' perception of nasal function. 2-5 Thus, disease-specific patient-reported outcome measures, such as the Nasal Obstruction Symptom Evaluation (NOSE), have become the primary metric by which the burden of nasal airway obstruction is measured and outcomes after treatment are assessed. 6 Owing to increasing pressure for health care systems to allocate their limited resources, decision makers are required to critically evaluate the benefits and costeffectiveness of medical and surgical interventions. The value of the additional time and resources that are required in open septorhinoplasty is often questioned. However, the value of an intervention can be assessed through health utility values (HUVs), a measure of preference-based healthrelated quality of life (QOL) that is often used by health economists in cost-utility analyses. 7 Furthermore, HUVs measure patient-reported outcomes in a common metric, allowing comparison between different chronic disease states. 8, 9 At present, evidence is limited on the effect of nasal airway obstruction, its effect as measured by HUVs, and the effect of open septorhinoplasty on HUVs in patients with nasal airway obstruction. The aim of this study was to assess the association of nasal airway obstruction from septal and nasal valve disorders with health outcomes as measured by HUVs and the subsequent association of open septorhinoplasty with patient health.
Methods

Study Design
In this case series study, consecutive adult patients ( Patients underwent open septorhinoplasty with or without turbinate reduction for nasal airway obstruction. All patients were determined by the treating surgeon to have a significant septal and/or nasal valve deformity through clinical examination, medical imaging, or a combination of both. Patients completed standardized patient-reported outcome measures, including the 36-Item Short Form Health Survey v2 Australia (SF-36), the Sino-Nasal Outcome Test 22 (SNOT-22), and the Nasal Obstruction Symptom Evaluation (NOSE) questionnaire, before and 6 months after the procedure.
Patient-Reported Outcome Measures
Nasal airway obstruction was assessed using a visual analog scale from 0 to 100 mm and the NOSE questionnaire. 10 The NOSE questionnaire is a 5-item survey developed to assess the subjective consequences of nasal airway obstruction in general, with each question scaled from 0 to 100, with higher numbers representing poorer health. The SNOT-22 was recorded as a disease-specific, patient-reported outcome measure of the prior 2 weeks of symptoms and has been described in the context of nasal airway obstruction. 11, 12 Scores on the SNOT-22 are scaled from 0 to 120, with higher numbers representing a significant problem to a patient's life. All patients completed an SF-36 QOL questionnaire. 13 The SF-36 is a generic patient-reported outcome measure, whereas the SNOT-22 and the NOSE questionnaire evaluate disease-specific QOL for nasal airway obstruction. The SF-36 questionnaire provides a physical component score and mental component score for each patient. After patients were given a decongestant, they completed the questionnaires in a quiet and comfortable environment while waiting for the decongestant to take effect before their consultation. Assistance was provided if clarifications were required, and more time was given as necessary to ensure full completion of the questionnaires.
HUV Assessment
Data from the SF-36, which was completed by patients before and after open septorhinoplasty, were converted into a Short Form 6D (SF-6D) utility score and HUVs using a weighted algorithm that was used with permission from the Department of Health Economics and Decision Science, University of Sheffield, Sheffield, United Kingdom. The algorithm generates the SF-6D utility score using a set of preference weights obtained from a sample of the Australian general population through the standard gamble technique. [14] [15] [16] The SF-6D is a validated classification system to describe health states derived from the SF-36, comprising 6 multilevel dimensions. Patients are classified into 1 of 18 000 health states depending on their individual response. Each health state c an then be translated into HUVs. This process allows the SF-6D to provide the means to obtain quality-adjusted life years from the SF-36, which can be used in cost-utility analyses to determine where health care resources should be most efficiently directed. 17 Health utility values are measured from a scale of 0 to 1, where 0 represents death and 1 represents perfect health. Measurements are placed on an interval scale, which means that changes are the same irrespective of where the HUVs are placed (for example, a change in HUV from 0.3 to 0.4 is equivalent to a change from 0.7 to 0.8). A change of 0.03 or more in HUV is regarded as the minimal clinically important difference (MCID) for a particular health state. 18 
Statistical Analysis
Statistical analysis was conducted with IBM SPSS statistics software, version 24.0 (SPSS Inc). Results are presented as mean (SD). Correlation between HUVs and baseline variables was performed using the Pearson correlation coefficient. The correlation coefficient (r score) obtained from the Pearson correlation test is stratified into weak (<0.3), moderate (0.3-0.5), and strong (>0.5). Differences in baseline variables and HUVs after surgery were analyzed using a paired t test. P < .05 was considered to be statistically significant, with 95% CIs.
Results
A total of 144 patients (85 women and 59 men; mean [SD] age, 38 [13] years) were assessed. Baseline demographic data, patient-reported outcome measure results, and HUVs are presented in Table 1 . The mean (SD) HUV for this patient population before nasal surgery was 0.72 (0.09), which was lower than the weighted mean (SD) norm of the Australian population of 0.81 (0.22).
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Association of HUVs With Other Measures of Disease Severity
Correlation between HUVs and other patient-reported outcome measures was assessed ( Table 2 ). Moderate to strong correlations were seen between HUVs and patients' perception of nasal patency derived from patient-reported outcome measures. Higher visual analog scale scores on the obstructed side (r = -0.38; P = .01) and higher NOSE scores (r = -0.48; P = .01) and SNOT-22 scores (r = -0.68; P = .01) (indicative of a subjectively higher degree of nasal obstruction) were correlated with lower HUVs, thus reflecting poorer QOL. 
Association of Open Septorhinoplasty With HUVs
Discussion
Many disease-specific, patient-reported outcome measures, including the SNOT-22 and NOSE questionnaires, have been validated and used in rhinologic studies to evaluate the effectiveness of medical and surgical interventions for nasal airway obstruction. 6,20,21 However, only a few studies have used generic patient-reported outcome measures, such as the SF-6D, to generate HUVs and evaluate the disease burden of nasal airway obstruction. Potentially, the change in health status of patients with nasal airway obstruction might be too subtle or disease specific to be assessed using the contents of a generic patient-reported outcome measure.
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Health utility values are unique because they quantify an individual's preference for their state of health. Unlike diseasespecific outcome measures, such as the SNOT-22 and NOSE questionnaires, HUVs provide a general QOL metric that allow comparison between various chronic disease states and interventions. Health utility values form the basis by which quality-adjusted life years are derived, and calculation of cost per quality-adjusted life year is then used to assess the costeffectiveness of treatments. A change of 0.03 in HUVs has been validated among many chronic disease states to indicate MCID that changes a patient's subjective well-being by at least 1 point on a 5-point global health rating of change (where 5 is much better health; 4, somewhat better health; 3, no change in health; 2, somewhat poorer health; and 1, much poorer health). Health utility values in this study were not directly obtained through SF-6D questionnaires but rather through the conversion of SF-36 data to SF-6D scores using a program from the University of Sheffield. The conversion was necessary to obtain HUVs; the SF-36 is not suitable for cost-utility analysis because it assumes that each item is of equal importance and does not enable tradeoffs between different dimensions of health (for instance, between quality and length of life or pain and physical functioning). The SF-6D, an abbreviated version of the SF-36, was designed to incorporate preference weights to each individual health state for use in cost-utility analysis. Preference weights were obtained from standard gamble health state valuation tasks completed by a large sample of the Australian population. 34 These valuations were fit in an ordinary least-squares regression to create an equation that can be used to convert any combination of the 6 domain levels to generate an SF-6D-derived HUV. 14 The conversion algorithm has been validated to reduce the mean absolute error of sample predictions and overcome bias of regression models in underpredicting poorer health states, therefore mitigating the inherent weakness of mapping the results from the SF-36. 15, 16 Moreover, this conversion algorithm has been used in other areas of health, including peripheral vascular and rheumatologic diseases.
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Strengths and Limitations
The SF-36 was selected as the generic patient-reported outcome measure for this study because its psychometric properties are well established and it is widely used throughout the world. 37 In addition, the SF-36 has a large descriptive system and is thus believed to have a greater degree of sensitivity. 15, 38 Several organizations, including the Australian Institute of Health and Welfare and Australian Bureau of Statistics, have adopted the use of the SF-36 to gather health data on a nationally representative population sample. 39 Application of the SF-36 in this study provided quantitative data that showed a benefit of open septorhinoplasty for generic patient-reported outcome measures and is a step toward future studies in costutility analysis.
With the results of this study, it must be taken into account that patient comorbidities were excluded in data collection; therefore, it is difficult to determine the contribution of other medical conditions and to isolate the effect of nasal airway obstruction to each individual patient. However, this study demonstrated an improvement in health (as defined by HUVs) and QOL regardless of comorbidities in a young patient population. The change in NOSE score after surgical intervention in this study did not reach the MCID of 30 or more. Regardless, the mean postoperative NOSE score was similar to the reported mean postoperative NOSE score of patients with nasal airway obstruction. 6 In addition, there is a lack of generalizability in this patient population because patients who underwent nasal surgery were recruited from specialized tertiary rhinologic centers. These patients may represent a specific group of patients with potentially more severe manifestations of nasal airway obstruction and may not be an accurate reflection of disease severity for an average patient with nasal airway obstruction.
A significant challenge in the interpretation of published utility values is the presence of other QOL instruments from which HUVs can be derived, such as the EuroQOL 5-Dimension, Health Utilities Index Mark 3, and Quality of Well-Being Index. Health utility values derived from different QOL instruments are not interchangeable owing to differing conceptualization, content, and methods. 40, 41 For instance, the mean (SD) HUV of the Australian population resulting from the SF-6D was in contrast with values resulting from the EuroQOL 5-Dimension. 42 Direct comparisons between HUVs derived from the SF-36 and EuroQOL 5-Dimension in nasal airway obstruction have yet to be described in the literature, to our knowledge. However, one study using the EuroQOL 5-Dimension visual analog scale score was able to detect a clinically significant improvement after functional septorhinoplasty for nasal airway obstruction. 43 Furthermore, both instruments show comparable gains in utility after endoscopic sinus surgery in the context of chronic rhinosinusitis, supporting the use of each instrument in cost-utility analysis.
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Conclusions
Patients with nasal airway obstruction in this study reported baseline HUVs that were lower than the Australian norm and comparable with those for individuals with chronic diseases with significant health expenditure. There was a clinically and statistically significant improvement in HUVs after surgical intervention that correlated with a reduction in NOSE and SNOT-22 scores. Outcomes from this study may be used for health economic analyses of the benefit associated with open septorhinoplasty. 
